KEY FEATURES
| Full Name | Ret Proto-Oncogene |
|---|---|
| Synonym | Proto-oncogene tyrosine-protein kinase receptor Ret,Cadherin family member 12,Proto-oncogene c-Ret, |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 3.12-200ng/mL |
| Sensitivity | 1.14ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human RET in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human RET. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human RET and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human RET, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human RET. You can calculate the concentration of Human RET in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human RET ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 9.22 | 31.18 | 72.35 | 8.74 | 29.61 | 66.33 |
| Standard deviation | 0.53 | 1.45 | 3.64 | 0.51 | 1.37 | 3.63 |
| CV(%) | 5.8 | 4.64 | 5.03 | 5.81 | 4.62 | 5.47 |
RECOVERY
The recovery of Human RET spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-100 | 94 |
| EDTA plasma (n=8) | 90-103 | 95 |
| Cell culture media (n=8) | 91-105 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human RET in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with RET ELISA Kits
| GDNF ELISA Kit | publications with RET and GDNF |
| GFRA1 ELISA Kit | publications with RET and GFRA1 |
| STAT3 ELISA Kit | publications with RET and STAT3 |
| GRB2 ELISA Kit | publications with RET and GRB2 |
| SHC1 ELISA Kit | publications with RET and SHC1 |
| PDLIM7 ELISA Kit | publications with RET and PDLIM7 |
| CRK ELISA Kit | publications with RET and CRK |
| DOK6 ELISA Kit | publications with RET and DOK6 |
| CBLC ELISA Kit | publications with RET and CBLC |
| DOK5 ELISA Kit | publications with RET and DOK5 |
Pathways associated with RET ELISA Kit
| Central Carbon Metabolism In Cancer Pathway | Central Carbon Metabolism In Cancer Pathway |
| Endocytosis Pathway | Endocytosis Pathway |
| Pathways In Cancer | Pathways In Cancer |
| SIDS Susceptibility Pathways | SIDS Susceptibility Pathways |
| Signaling Events Regulated By Ret Tyrosine Kinase Pathway | Signaling Events Regulated By Ret Tyrosine Kinase Pathway |
| Thyroid Cancer Pathway | Thyroid Cancer Pathway |
Diseases associated with RET ELISA Kit
| Thyroid Neoplasms | publications with RET and Thyroid Neoplasms |
| Carcinoma, Medullary | publications with RET and Carcinoma, Medullary |
| Multiple Endocrine Neoplasia | publications with RET and Multiple Endocrine Neoplasia |
| Multiple Endocrine Neoplasia Type 2a | publications with RET and Multiple Endocrine Neoplasia Type 2a |
| Pheochromocytoma | publications with RET and Pheochromocytoma |
| Hirschsprung Disease | publications with RET and Hirschsprung Disease |
| Nervous System Diseases | publications with RET and Nervous System Diseases |
| Multiple Endocrine Neoplasia Type 2b | publications with RET and Multiple Endocrine Neoplasia Type 2b |
| Hyperplasia | publications with RET and Hyperplasia |
| Familial medullary thyroid carcinoma | publications with RET and Familial medullary thyroid carcinoma |
Organs/Tissues associated with RET ELISA Kit
| Blood | publications with RET and Blood |
| Nerve | publications with RET and Nerve |
| Brain | publications with RET and Brain |
| Adrenal Gland | publications with RET and Adrenal Gland |
| Kidney | publications with RET and Kidney |
| Embryonic Tissue | publications with RET and Embryonic Tissue |
| Eye | publications with RET and Eye |
| Liver | publications with RET and Liver |
| Heart | publications with RET and Heart |
| Testis | publications with RET and Testis |